Clinical Trial Update: Trial of Rituximab for Graves' Ophthalmopathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on rituximab for Graves' ophthalmopathy (thyroid-associated ophthalmopathy) covering Phase 2 and Phase 3; the trial is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Rebecca Bahn | Conditions: Thyroid-associated Ophthalmopathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-06-03